- Research Areas
- Clinical Solutions
- Contact Us
The Centers for Disease Control and Prevention ranks cancer as one of the leading causes of death in the United States. Although a tremendous amount of effort has focused on eradicating cancer, we have only achieved modest overall success. Why? Cancer is characterized by "multivariate dysregulation and highly heterogeneous pathology", which complicates therapeutic efforts. As such, investigators need actionable insights in order to confront this scourge.
Bio-Techne is uniquely positioned to empower the cancer research community to discover, validate and verify biomarker candidates that expedite the development of therapeutic interventions.
ExosomeDX, a Bio-Techne brand wants to partner with you to expedite your biomarker discovery workflow. Collaborate with our pharma services group to leverage the power of exosomes from biomarker discovery to companion diagnostic development and clinical trial support!
We provide solutions for hypothesis-driven research and development! Uncover novel biomarker candidates yourself or partner with ExosomeDx, a Bio-Techne Brand.
Assess your biomarker candidates for analytical and technical reproducibility. Identify biomarkers that you can track longitudinally in a companion diagnostic.
Evaluate biomarkers for use in companion diagnostics. Automate biomarker assessment with sensitive and specific assays so that you can easily stratify subjects in your studies.